Outsourcing in pharmaceutical manufacturing: Enhancing quality while managing risk
BY David Lange, Director, Governance, Risk and Compliance Services, Weaver The pharmaceutical industry is undergoing a fundamental transformation in how drugs are manufactured. As regulatory requirements grow more complex and quality standards become increasingly stringent, companies are reevaluating their manufacturing strategies. The global pharmaceutical contract manufacturing market, projected to exceed $120 billion by 2025, reflects a growing trend toward outsourced manufacturing as a means to enhance quality, ensure compliance and optimize costs. Current...